Annual report pursuant to Section 13 and 15(d)

RESTRUCTURING AND SEVERANCE EXPENSES

v3.20.4
RESTRUCTURING AND SEVERANCE EXPENSES
12 Months Ended
Dec. 31, 2020
Restructuring and Related Activities [Abstract]  
RESTRUCTURING AND SEVERANCE EXPENSES RESTRUCTURING AND SEVERANCE EXPENSESDuring 2018, the Company incurred restructuring and severance expenses of approximately $2.3 million related to changes in executive management and the completion of significant capital projects in our specialty petrochemicals segment. These expenses related to severance, stock compensation for continued vesting of time-vested shares issued under the Company’s long-term incentive plans, and certain employee benefits including medical insurance and vacation. As of December 31, 2020, there was no remaining unpaid or accrued restructuring or severance expenses. As of December 31, 2019, approximately $0.02 million remained unpaid and was included in accrued liabilities.